Cargando…
A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis
Despite much effort to improve treatments, patients with malignant glioma still present a very poor prognosis that has not changed significantly in the last decades. In this context, it is crucial to better understand glioma pathogenesis to identify new molecular prognostic subgroups and therapeutic...
Autores principales: | Gonçalves, Céline S., Xavier‐Magalhães, Ana, Martins, Eduarda P., Pinto, Afonso A., Pires, Manuel Melo, Pinheiro, Célia, Reis, Rui M., Sousa, Nuno, Costa, Bruno M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266278/ https://www.ncbi.nlm.nih.gov/pubmed/31923345 http://dx.doi.org/10.1002/1878-0261.12633 |
Ejemplares similares
-
A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide
por: Pojo, Marta, et al.
Publicado: (2015) -
Transcriptional profiling of HOXA9-regulated genes in human glioblastoma cell models
por: Gonçalves, Céline S., et al.
Publicado: (2015) -
WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma
por: Gonçalves, Céline S., et al.
Publicado: (2018) -
Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma
por: Se, Young-Bem, et al.
Publicado: (2017) -
Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma
por: Vieira de Castro, Joana, et al.
Publicado: (2021)